An update on thrombosis prophylaxis in orthopaedic and accident surgery;Update der thromboseprophylaxe in orthopädie und unfallchirurgie

Orthopade

Volumn 33, Issue 7, 2004, Pages 762-773

  Grifka, J ^a   Haas, S ^b   Hovy, L ^c   Knopp, W ^d   Refior, H L ^e   Schurmann M ^f   Wirth, T ^g  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Orthopädische Klinik ^*

^c SAARLAND UNIVERSITY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Guidelines; Orthopaedic surgery; Prevention of thrombosis; Trauma surgery; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; DESULFATOHIRUDIN; FONDAPARINUX; HEPARIN; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; PHENPROCOUMON; THROMBIN INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; WARFARIN; XIMELAGATRAN;

ACCIDENT; ANTICOAGULATION; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; HUMAN; MEDICOLEGAL ASPECT; ORTHOPEDIC SURGERY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOSIS PREVENTION; TREATMENT INDICATION;

ANTICOAGULANTS; EVIDENCE-BASED MEDICINE; HUMANS; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; THROMBOEMBOLISM; WOUNDS AND INJURIES;

EID: 3442878185     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Agu O, Hamilton G, Baker D (1999) Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 86: 992-1004
2. AWMF-Leitlinien-Register Nr.003/001
3. Bergqvist D, Jendteg S, Johansen L (1997) Cost of long-term complications of deep venous thrombosis of the lower extremities: An analysis of a defined patient population in Sweden. Ann Intern Med 126: 454-457
4. Bergqvist D, Jönsson B (2000) Cost-effectiveness of prolonged out-of-hospital prophylaxis with low-molecular-weight heparin following total hip replacement. Haemostasis 30: 130-135
5. Bounameaux H (1999) Integrating pharmacological and mechanical prophylaxis of venous thromboembolism. Thromb Haemost 82: 931-937
6. Caprini JA, Botteman MF, Stephens JM (2003) Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value in Health 6: 59-74
7. Collins R, Yusuf S, Scrimgeour A, Peto R (1988) Substantial reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomised trials in general, orthopedic, and urologic surgery. N Engl J Med 318: 1162-1173
8. Comp PC, Spiro TE, Friedman RJ et al. (2001) Prolonged Enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg (Am) 83: 336-345
9. Dahl OE, Gudmundsen TE, Haukeland L (2000) Late occuring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 71: 47-50
10. Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358: 9-15
11. Eriksson BI, Lassen MR (2003) Pentasaccharide in Hip-Fracture Surgery Plus Investigators: Duration of prophylaxis against venous thromboembolism with Fondaparinux after hip fracture surgery: a multicenter, randomised, placebo-controlled, double-blind study. Arch Int Med 163: 1337-1342
12. Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M; METHRO III Study Group (2003) Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost 89: 288-296
13. Eriksson BI (2003) Clinical experience of melagatran/ximelagatran in major orthopaedic surgery. Thromb Res 109 (Suppl): S23-29
14. Geerts WH, Heit JA, Clagett GP (2001) Prevention of venous thromboembolism. Chest 119: 132
15. Greinacher A, Lubenow N, Hinz P, Ekkernkamp A (2003) Heparininduzierte Thrombocytopenie. Dtsch Ärztebl 100: A2220-2229
16. Gustafsson D, Elg M (2003) The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res. 109 (Suppl 1): S9-15
17. Haas S (1997) Prevention, Diagnostik und Therapie von Thrombosen in der Orthopädie und Unfallchirurgie. Orthopäde 26: 1062-1074
18. Haas S (2003) Medical indications and considerations for future clinical decision making. Thromb Res 109 (Suppl 1): S31-7
19. Heit JA (2001) Low-molecular-weight heparin: The optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement. Thromb Res 101: V163-V173
20. Hull RD, Pineo GF (1999) Extended prophylaxis against venous thromboembolism following total hip and knee replacement. Haemostasis 29 (Suppl 1): 23-31
21. Kujath P, Spannagel W, Habscheid G, Schindler G, Weckbach A (1992) Thromboseprophylaxe bei ambulanten Patienten mit Verletzungen der unteren Extremität. DMW 117: 6-10
22. Lassen MR, Borris LC, Nakov RL (2002) Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 347: 726-730
23. Lohr JM, James KV, Deshmukh RM, Hasselfeld KA (1995) Calf vein thrombi are not a benign finding. Am J Surg 170: 86-90
24. Menzin J, Colditz GA, Regan MM (1995) Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery. Arch Intern Med 155: 757-764
25. Mizel MS, Temple HAT, Michelson JD (1998) Thromboembolism after foot and ankle surgery. A multicenter study. Clin Orthop 348: 180-185
26. O'Donnell M, Linkins LA, Kearon C, Julian J, Hirsh J (2003) reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. Arch Intern Med 163: 1362-1366
27. Pellegrini VD Jr, Langhans MJ, Totterman S, Marder VJ, Francis CW (1993) Embolic complications of calf thrombosis following total hip arthroplasty. J Arthroplasty 8: 449-457
28. Prandoni P, Bruchi O, Sabbion P et al. (2002) Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomised study. Arch Intern Med 162: 1966-1971
29. Salzmann EW, Davies GC (1980) Prophylaxis of venous thromboembolism. Analysis of cost effectiveness. Ann Surg 191: 207-218
30. Schippinger G, Wirnsberger GH, Obernosterer A, Babinski K (1998) Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients. Acta Orthop Scand 69: 144-146
31. Szucs TD, Schramm W (1999) The cost-effectiveness of low-molecular-weight heparin vs unfractionated heparin in general and orthopaedic surgery: an analysis für the German healthcare system. Pharmacol Res 40: 83-89
32. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 162: 1833-1840
33. Ulsenheimer K (2001) Rechtliche Aspekte bei der Phrophylaxe und Therapie der venösen Thrombose. Chirurg BDC 4: 104-110
34. Virchow R (1856) Phlogose und Thrombose im Gefäßsystem. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. von Meininger, Berlin, III: 458-635
35. Wells PS, Lensing AWA, Hirsh J (1996) Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. Arch Intern Med 154: 67-72
36. Wirth T, Schneider B, Misselwitz F, Lomb M, Tüylü H, Egbring R, Griss P (2001) Prevention of venous thromboembolism after knee arthroscopy with low molecular weight heparin (reviparin). Results of a randomised controlled trial. Arthroscopy 17: 393-399